Atlas Trials

Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study

Clinical trial NCT05612594 · RECRUITING

Trial details

NCT number
NCT05612594
Sponsor
Yale University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Sleep Apnea
Start date
2024-03-27
Primary completion
2027-09-01
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.